DANIELLE BOWEN: Open Payments
NPI 1780874297 · FAYETTEVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 30 payments from 16 companies in 2025. Trend: 2023 $1,486 · 2024 $889 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Stryker Corporation | 1 | $163 |
| Gilead Sciences, Inc. | 2 | $148 |
| ABBVIE INC. | 4 | $95 |
| Daiichi Sankyo Inc. | 3 | $69 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Legend Biotech USA Inc. | 3 | $58 |
| PFIZER INC. | 3 | $56 |
| Janssen Biotech, Inc. | 2 | $40 |
| Eisai Inc. | 2 | $36 |
| GENZYME CORPORATION | 1 | $28 |
Products named: OPTABLATE, Trodelvy, VENCLEXTA, KEYTRUDA, CARVYKTI, DATROWAY, Lenvima, CABLIVI.
Industry payments across GA — which companies pay providers there.
